期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非小细胞肺癌中胰岛素样生长因子-1受体的表达 被引量：1

原文传递
导出
摘要 胰岛素样生长因子1受体（insulin like growth factor—Ireceptor，IGF—IR）是一种跨膜的酪氨酸蛋白受体。对细胞的分裂分化和增殖具有重要的调控作用。本实验以手术切除的NSCLC组织及其临近的正常肺组织为研究对象。采用免疫组织化学的方法对癌组织、癌旁组织和正常肺组织中IGF—IR的表达和分布进行检测分析和比较，为寻我和选择肿瘤细胞特异的靶点提供方向。
作者 余宗阳 欧阳学农 杜建 季天海 李捷
机构地区 福州总医院肿瘤科 福州总医院病理科
出处 《福州总医院学报》 2006年第4期202-204,共3页 Journal of Fuzhou General Hospital
关键词 非小细胞肺癌 岛素样生长因子-1 蛋白受体 胰岛素样生长因子1 NSCLC组织 免疫组织化学 调控作用 手术切除
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献2

二级参考文献13

  • 1Long L,Rubin R,Brodt P.Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor[J].Exp Cell Res,1998,238(1):116-121.
  • 2Jones JI,Clemmons DR.Insulin-like growth factors and their binding proteins:biological actions(Review)[J]. Endocr Rev,1995,16(1):3-33.
  • 3Sell C,Dumenil G,Deveaud C,et al. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts[J]. Mol Cell Biol,1994,14(6):3604-3612.
  • 4Khandwala HM, McCutcheon IE, Flyvbjerg A,et al.The effects of insulin-like growth factors on tumorigenesis and neoplastic growth[J]. Endocr Rev,2000,21(3):215-244.
  • 5Moschos SJ,Mantzoros CS.The role of the IGF system in cancer: from basic to clinical studies and clinical applications[J].Oncology,2002,63(4):317-332.
  • 6Baserga R.The IGF-1 receptor in cancer research[J].Exp Cell Res,1999,253(1):1-5.
  • 7Reiss K,Ferber A,Travali S,et al.The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism[J].Cancer Res,1991,51(21):5997-6000.
  • 8De Meyts P, Urso B , Christoffersen CT, et al.Mechanism of insulin and IGF-1 receptor activation and signal transduction specific:receptor dimer cross-linking,bell-shaped curves,and sustained versus transient signaling(Review)[J].Ann NY Acad Sci,1995,766(
  • 9Hellawell GO,Turner GD,Davies DR,et al. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease[J].Cancer Res,2002,62(10):2942-2950.
  • 10Pertz S,Kim C,Rockwell S,et al. IGF1 receptor expression protects against microenvironmental stress found in the solid tumor[J].Radiat Res,2002,158(2):174-180.

共引文献5

同被引文献51

  • 1Piperdi B, Merla A, Perez-Soler R. Targeting angiogenesis in squamous nonsmall cell lung cancer. Drugs, 2014, 74(4): 403-413.
  • 2Mitsudomi T, Morita S, Yatabe Y, ei al. Updated overall survival results of WJTOG 3405, a randomized phase III trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer harboring mutations of the epidermal growth factor receptor (EGFR).J Clin Oncol, 2012, 30 (Suppl). Abstr 7521.
  • 3Mok TS, Wu YL, Yu cj, et al. A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II.J Clin Oncol, 2012, 30(Supp!): Abstr 7520.
  • 4Mu XL, Li LY, Zhang XT, et al. Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in Chinese patients with nonsmall cell lung cancer. Clin Cancer Res, 2005, 1l(12): 4289-4294.
  • 5Lai Y, Zhang Z, LiJ, et al. EGFR mutations in surgically resected fresh specimens from 697 consecutive Chinese patients with non-small cell lung cancer and their relationships with clinical features. IntJ Mol Sci, 2013, 14(12): 24549-24559.
  • 6Hata A, Katakami N, Yoshioka H, et al. How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations?J Thorac Oncol, 2013, 8( 1): 89-95.
  • 7Shukuya T, Takahashi T, Kaira R, et al. Efficacy of gefitinib for nonadeancareinoma non-small cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published reports. Cancer Sci, zou, 102(5): 1032-1037.
  • 8Yamamoto H, Shigematsu H, Nomura M, et al. PIK3CA mutations and copy number gains in human lung cancers. Cancer Res, 2008, 68( 17): 69l3-6921.
  • 9Ligresti G, Militello L, Steelman LS, et al. PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches. Cell Cycle, 2009,8(9): l352-l358.
  • 10Courtney KD, Corcoran RB, Engelman JA. The PI3K pathway as drug target in human cancer.J Clin Oncol, 2010, 28(6): 1075-1083.

引证文献1

二级引证文献11

福州总医院学报
2006年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部